Company Monitoring Page for Merck

latest headlines for company on cafepharma

FDA skeptical of Merck’s gefapixant, even after cough recount
Fierce Biotech
Thu, 11/16/23 - 11:34 am
Tags:
Merck, chronic cough, gefapixant
Merck-backed VectorY Therapeutics raises $138M series A to push forward ALS program
Fierce Biotech
Tue, 11/14/23 - 09:28 am
Tags:
VectorY Therapeutics, funding, ALS, Merck
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Motley Fool
Sun, 11/12/23 - 09:30 pm
Tags:
Merck, Bristol Myers Squibb, antibody-drug conjugate
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Tags:
Merck, AstraZeneca, biliary tract cancer, Keytruda, Imfinzi
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Tags:
Daiichi Sankyo, Merck, antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
Tags:
AbbVie, Daiichi Sankyo, Merck, antibody-drug conjugate
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
Tags:
earnings, Bristol Myers Squibb, Takeda, Novartis, Sanofi, Merck
Merck quarterly profit tops expectations on COVID pill surprise
Yahoo/Reuters
Thu, 10/26/23 - 10:53 pm
Tags:
Merck, earnings, COVID-19
Merck terminates Phase II trials for Alzheimer’s drug due to liver toxicity
Clinical Trials Arena
Thu, 10/26/23 - 11:53 am
Tags:
Merck, clinical trials, MK-1942, liver toxicity, Alzheimer's disease
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters
Tue, 10/24/23 - 10:00 am
Tags:
Merck, Sichuan Kelun Pharmaceutical, cancer, oncology
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
Tags:
ESMO, Merck, Bristol Myers Squibb, bladder cancer, PD-1 inhibitors, Keytruda, Padcev, Opdivo
Merck's early KRAS data suggest combination-friendly safety
Fierce Biotech
Mon, 10/23/23 - 10:30 am
Tags:
Merck, ESMO, KRAS inhibitors, Amgen, Lumakras
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
Mon, 10/23/23 - 09:07 am
Tags:
ESMO, AstraZeneca, Merck, Lynparza, endometrial cancer
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
Tags:
ESMO, Bristol Myers Squibb, Opdivo, bladder cancer, Padcev, Keytruda, Merck
ESMO: In PD-1 battle GSK waged on Merck, Jemperli appears to show survival edge over Keytruda in lung cancer
Fierce Pharma
Fri, 10/20/23 - 11:47 am
Tags:
Merck, GSK, Keytruda, Jemperli, ESMO, nonsquamous non-small cell lung cancer
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Tags:
Merck, Daiichi Sankyo, AstraZeneca, antibody-drug conjugate
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:38 am
Tags:
Seagen, Astellas, Merck, Padcev, Keytruda, bladder cancer, ESMO
Merck Pushes Keytruda into Perioperative NSCLC Setting with FDA Approval
BioSpace
Tue, 10/17/23 - 09:36 pm
Tags:
Merck, Keytruda, non-small cell lung cancer
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Tags:
Merck, Keytruda, non-small cell lung cancer
Eikon cuts staff 'to become more efficient,' letter from CEO Perlmutter reveals
Fierce Biotech
Sun, 10/8/23 - 02:44 pm
Tags:
Eikon Therapeutics, Roger Perlmutter, Merck, layoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.